bifico

DRUG3 trials

Sponsors

Tongji Hospital, Shanghai 10th People's Hospital

Conditions

BifidobacteriumGut MicrobiotaHepatocellular CarcinomaHirschsprung's Disease Associated EnterocolitisProbioticsProbiotics Plus Chemotherapy

Early Phase 1

A Trial on Probiotics in Preventing Hirschsprung's Disease Associated Entercolitis

CompletedNCT01934959

Tongji HospitalHirschsprung's Disease Associated Enterocolitis, Probiotics

Start: 2008-01-31Updated: 2013-09-04

Phase 3

Probiotics Combined With Chemotherapy for Patients With Advanced NSCLC

Shanghai 10th People's HospitalProbiotics Plus Chemotherapy

Start: 2019-02-21End: 2024-03-01Target: 180Updated: 2019-02-25

Unknown Phase

Clinical Study on BIFICO Accelerating Postoperative Liver Function Recovery in Patients With Hepatocellular Carcinoma

CompletedNCT05178524

Tongji HospitalBifidobacterium, Gut Microbiota, Hepatocellular Carcinoma

Start: 2021-06-01End: 2022-06-30Updated: 2022-09-02

Related Papers

Investigating efficacy of “microbiota modulation of the gut-lung Axis” combined with chemotherapy in patients with advanced NSCLC: study protocol for a multicenter, prospective, double blind, placebo controlled, randomized trial

BMC Cancer2021-06-2217 citations

Probiotics prevent Hirschsprung's disease-associated enterocolitis: a prospective multicenter randomized controlled trial.

2014-11-0537 citations